News | June 04, 2021
Lupin launches generic version of Brovana in US
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
US revenues were sequentially stable at US$370mn with steady performance in the specialty portfolio
The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
The company plans to enter the EU markets in FY22
This kit was developed in partnership with Gujarat-based LabCare Diagnostics. LabCare is into clinical chemistry reagents, serology tests, immuno-chromatographic tests and urine analysis strips
In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries
Zydus was the first ANDA applicant to submit a substantially complete ANDA with a paragraph IV certification for Ibrutinib Capsules, 70 mg.
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
The DREAM-ND Phase III trial has now enrolled 588 CKD patients not-on-dialysis.
Subscribe To Our Newsletter & Stay Updated
